輸液儀器：技術與全球市場

輸液儀器：技術與全球市場 是由出版商BCC Research在2010年02月所出版的。 這份英文市場調查報告書包含194 pages 價格從美金4850起跳。

簡介

本研究報告聚焦於醫院與研究機關、診所等終端用戶，檢視全球2008年輸液儀器市場實績與2009〜2014年預測、技術動向等情報，內容摘記如下。

第1章 序論

第2章 摘要

第3章 概況

第4章 主要企業與市場占有率

• 主要企業與市場占有率
• 主要市場
  • 美國
  • 日本
  • 加拿大
  • 澳洲

第5章 產品別市場

• 產品別市場
• 彈性與機械式輸液幫浦
• 彈性幫浦
• 蠕動幫浦
• 卡匣幫浦
• 注射幫浦
• 電動注射輸液幫浦
• 植入型輸液幫浦

第6章 應用

第7章 使用狀況

• 狀況
• 疼痛管理
• 投藥
• 糖尿病
• 小腸營養補給
• PN
• 抗生素

第8章 競爭・互補技術

• 無針注射
• 胰島素筆
• 迷你包裝
• 血糖値檢測
• 血糖値自我監控
• CGMS
• 常規胰島素給藥
• 破壞性技術挑戰
• 輸液劑與儀器
• 奈米科技
• 生物科技

第9章 政府法規

• 美國FDA
• FDA的上市前檢視
• 回收
• FDA與各州政府
• Medicare與Medicaid

第10章 専家團隊的臨床指引

• Joint Commission
• ECR機構
• Institute for Safe Medication Practice
• Association for the Advancement of Medical Instrumentation
• ISO

第11章 患者安全性

• 介紹
• 輸液幫浦
• 胰島素筆
• 無針注射
• IIPS
• 彈性輸液幫浦

第12章 業界結構

• 業界推進力
• 現在實績
• 業界課題
• 製造業者
• 販賣業者
• 政府・法規機構
• 保險公司
• 醫院　等

第13章 國際面

第14章 價格動向

第15章 技術、專利評價

第16章 企業檔案

第17章 附錄

目錄

Abstract

• Focus on end-user markets, including hospitals, research facilities, freestanding clinics, and doctors' offices that use the devices to administer therapeutics such as analgesics, antimicrobials, blood products, chemotherapy, and nutrients.
• Provide data on the global market for the devices in 2008, and forecast the market from 2009 through 2014.
• Discuss well-established technologies, such as electronic syringe infusion devices, injection pens, needleless jet injectors, as well as emerging technologies, such as transdermal drug delivery for illnesses such as cardiovascular disease.
• Examine improvements in quality, effectiveness, and safety.

STUDY GOALS AND OBJECTIVES

BCC' s goal in conducting this study was to determine the current status of the global market for infusion pumps and assess its growth potential over a 5-year period from 2009 to 2014. Of particular interest were changes to the regulatory environment and delivery infrastructure due to healthcare reform in the U.S. and other countries, and the rapid changes in product offerings following a series of high-profile product recalls over the past 2 years.

In addition, BCC was interested in describing the transition to “smart pump” technology and giving an overview of the complex systems that complement and compete with infusion pumps as mode of treatment.

The key objective was to present a comprehensive analysis of the current market for infusion pumps and its future growth prospects in providing safe and effective delivery of medications, nutrients, and analgesics.

REASONS FOR DOING THE STUDY

Almost every aspect of the infusion pump sector is undergoing dramatic change at this time. In response to numerous product recalls, manufacturers have introduced new smart pump technology to reduce Adverse Drug Events (ADEs) and other serious problems associated with previous administrative methods.

Competition from other drug delivery systems, chiefly transdermal and inhaled medicines, may put boundaries on growth for infusion pumps. Demand is growing for continuous administration of medicines and analgesics due to demographic changes in the world' s population and the increasing incidence of diabetes. Ancillary devices such as meters and monitors are becoming a significant force in the market, and design changes have produced new pumps that are smaller, less obtrusive, and have a sense of style, rendering them much more acceptable as ambulatory infusion pumps.

BCC is interested in charting the interplay between these various factors and how they will interact with other changes occurring in the broader landscape of healthcare delivery.

SCOPE OF REPORT

This report covers infusion pumps used for continuous or intermittent administration of medications (including antibiotics), nutrients, and analgesics. BCC analyzes current conditions in the global market and examines the current market condition and variable factors to forecast the future growth of the market. Medical, scientific, technological, social, and economic issues associated with this market are examined. An educated estimate and forecast of growth from 2009 to 2014 are presented by examining the current market and variable factors of each category of diagnostic or therapeutic product.

INFORMATION SOURCES

BCC surveyed approximately 45 companies to obtain data for this study. Included were manufacturers of infusion pumps, transdermal drug delivery systems, inhaled medications, glucose monitoring devices, medical device distributors, pharmaceutical manufacturers, and manufacturers of needleless injectors. BCC also spoke with government agency regulators, industry personnel, and medical science personnel. In addition, data was compiled from current financial, legal, trade information, and government sources.

ANALYST CREDENTIALS

Thomas Fuller has been a market research analyst for 15 years and has published numerous reports on technology products and market issues. Fuller has broad experience in covering regulatory and consumer issues, and currently advises companies on business strategy in the healthcare sector.

Table of Contents

Infusion Devices: Technologies and Global Markets

Chapter- 1: INTRODUCTION -- Complimentary

• STUDY GOALS AND OBJECTIVES
• REASONS FOR DOING THE STUDY
• SCOPE OF REPORT
• INTENDED AUDIENCE
• INFORMATION SOURCES
• ANALYST CREDENTIALS
• RELATED BCC REPORTS
• BCC ONLINE SERVICES
• DISCLAIMER

Chapter-2: SUMMARY

• SUMMARY
• SUMMARY (CONTINUED)
• SUMMARY TABLE GLOBAL INFUSION PUMP EXPENDITURES BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS)
• SUMMARY FIGURE GLOBAL INFUSION PUMP SPENDING BY GEOGRAPHIC REGION, 2008-2014 ($ MILLIONS)

Chapter-3: OVERVIEW

• INDUSTRY DEFINITION
• INFUSION PUMPS
• Importance of Infusion Pumps
• General
• Drug-delivery Systems
• Drug-...(Continued)
• Product and Technology Life Cycle
• HISTORY OF INFUSION
• HISTORY OF INFUSION (CONTINUED)
• INDUSTRY DEVELOPMENT
• FORECAST
• CURRENT ACTIVITY
• CURRENT STATE OF INFUSION DEVICES AND THERAPIES
• DEMAND AND COST
• DEMOGRAPHIC FACTORS
• Demographic Factors (Continued)
• 2009 IN REVIEW
• INDUSTRY DEVELOPMENTS
• CAREFUSION/ALARIS
• SMITHS MEDICAL
• BAXTER, COLLEAGUE, SIGMA, AND SPECTRUM
• KIMBERLY CLARK AND I-FLOW
• MEDINGO
• MOOG ROLL-UP STRATEGY
• YEAR(S) OF THE RECALL
• DEVELOPMENTS OUTSIDE THE INDUSTRY
• PORTABLE DIALYSIS MACHINE
• ISLET CELL INJECTION
• U.S. HEALTHCARE REFORM
• MEDICAL DEVICE MANUFACTURERS TAX
• HOME INFUSION THERAPY
• MEDICAL DEVICES REGISTRY
• SUNSHINE PROVISION
• COMPARATIVE EFFECTIVENESS RESEARCH

Chapter-4: MAJOR COMPANIES AND MARKET SHARE

• MAJOR COMPANIES AND MARKET SHARE
  • TABLE 1 GLOBAL MEDICAL INFUSION PUMP EXPENDITURES BY TYPE OF PUMP, THROUGH 2014 ($ MILLIONS)
  • FIGURE 1 GLOBAL MEDICAL INFUSION PUMP EXPENDITURES, 2008-2014 ($ MILLIONS)
• MAJOR MARKETS
  • FIGURE 2 HEALTHCARE EXPENDITURES AS PERCENTAGE OF GDP (%)
• U.S.
• JAPAN
• CANADA
• AUSTRALIA

Chapter-5: MARKETS BY PRODUCT

• MARKETS BY PRODUCT
• ELASTOMERIC AND MECHANICAL INFUSION PUMPS
• ELASTOMERIC PUMPS
• PERISTALTIC PUMPS
• CASSETTE PUMPS
  • TABLE 2 GLOBAL MANUFACTURERS OF ELASTOMERIC AND MECHANICAL INFUSION PUMPS MARKET SHARE, 2008 (%)
  • FIGURE 3 GLOBAL MANUFACTURERS OF ELASTOMERIC AND MECHANICAL INFUSION PUMPS GLOBAL MARKET SHARE, 2008 (%)
  • TABLE 3 GLOBAL MEDICAL ELASTOMERIC AND MECHANICAL INFUSION PUMP EXPENDITURES BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS)
  • TABLE 4 U.S. MEDICAL ELASTOMERIC AND MECHANICAL INFUSION PUMP MARKET BY SECTOR, THROUGH 2014 ($ MILLIONS)
• SYRINGE PUMPS
  • TABLE 5 GLOBAL SYRINGE INFUSION PUMP MANUFACTURERS' MARKET SHARE BASED ON DOLLAR SALES, 2008 (%)
  • FIGURE 4 GLOBAL SYRINGE INFUSION PUMP MANUFACTURERS' MARKET SHARE BASED ON DOLLAR SALES, 2008 (%)
  • TABLE 6 GLOBAL MEDICAL SYRINGE INFUSION PUMP EXPENDITURES BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS)
  • TABLE 7 U.S. MEDICAL SYRINGE INFUSION PUMP EXPENDITURES BY MARKET SECTOR, THROUGH 2014 ($ MILLIONS)
• ELECTRONIC SYRINGE INFUSION PUMPS
  • TABLE 8 GLOBAL ELECTRONIC SYRINGE INFUSION PUMP MANUFACTURERS' MARKET SHARE BASED ON DOLLAR SALES, 2008 (%)
  • FIGURE 5 GLOBAL ELECTRONIC SYRINGE INFUSION PUMP MANUFACTURERS' MARKET SHARE BASED ON DOLLAR SALES, 2008 (%)
  • TABLE 9 GLOBAL ELECTRONIC SYRINGE INFUSION PUMP EXPENDITURES BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS)
  • TABLE 10 GLOBAL ELECTRONIC SYRINGE PUMP EXPENDITURES BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS)
  • TABLE 11 U.S. ELECTRONIC SYRINGE INFUSION PUMP EXPENDITURES BY MARKET SECTOR, THROUGH 2014 ($ MILLIONS)
• IIPS
• IIPs (Continued)
  • TABLE 12 GLOBAL IMPLANTABLE INFUSION PUMP MANUFACTURERS' MARKET SHARE BASED ON DOLLAR SALES, 2008 (%)
  • FIGURE 6 GLOBAL IMPLANTABLE INFUSION PUMP MANUFACTURERS' MARKET SHARE BASED ON DOLLAR SALES, 2008 (%)
  • TABLE 13 U.S. IMPLANTABLE INFUSION PUMP EXPENDITURES BY MARKET SECTOR, THROUGH 2014 ($ MILLIONS)
  • TABLE 14 GLOBAL MEDICAL IMPLANTABLE INFUSION PUMP EXPENDITURES BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS)

Chapter-6: TYPES OF APPLICATIONS

• VOLUMETRIC INFUSION PUMPS
  • TABLE 15 GLOBAL VOLUMETRIC INFUSION PUMP MANUFACTURERS' MARKET SHARE BASED ON DOLLAR SALES, 2008 (%)
  • FIGURE 7 GLOBAL VOLUMETRIC INFUSION PUMP MANUFACTURERS' MARKET SHARE BASED ON DOLLAR SALES, 2008 (%)
  • TABLE 16 GLOBAL VOLUMETRIC INFUSION PUMP EXPENDITURES BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS)
  • TABLE 17 U.S. VOLUMETRIC INFUSION PUMP EXPENDITURES BY MARKET SECTOR, THROUGH 2014 ($ MILLIONS)
• SMART PUMPS
  • TABLE 18 GLOBAL SMART PUMP MANUFACTURERS' MARKET SHARE BASED ON DOLLAR SALES, 2008 (%)
  • FIGURE 8 GLOBAL SMART INFUSION PUMP MANUFACTURERS' MARKET SHARE BASED ON DOLLAR SALES, 2008 (%)
  • TABLE 19 GLOBAL SMART INFUSION PUMP EXPENDITURES BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS)
  • TABLE 20 U.S. SMART INFUSION PUMP EXPENDITURES BY MARKET SECTOR, THROUGH 2014 ($ MILLIONS)
• SMART PUMPS (CONTINUED)
• AMBULATORY INFUSION PUMPS
  • TABLE 21 GLOBAL AMBULATORY INFUSION PUMP MANUFACTURERS' MARKET SHARE BASED ON DOLLAR SALES, 2008 (%)
  • FIGURE 9 GLOBAL AMBULATORY INFUSION PUMP MANUFACTURERS' MARKET SHARE BASED ON DOLLAR SALES, 2008 (%)
  • TABLE 22 GLOBAL AMBULATORY INFUSION PUMP EXPENDITURES BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS)
  • TABLE 23 U.S. AMBULATORY INFUSION PUMP EXPENDITURES BY MARKET SECTOR, THROUGH 2014 ($ MILLIONS)
• INSULIN PUMPS
• INSULIN PUMPS (CONTINUED)
  • TABLE 24 GLOBAL INSULIN PUMP MANUFACTURERS' MARKET SHARE BASED ON DOLLAR SALES, 2008 (%)
  • FIGURE 10 GLOBAL INSULIN PUMP MANUFACTURERS' MARKET SHARE BASED ON DOLLAR SALES, 2008 (%)
  • TABLE 25 GLOBAL INSULIN INFUSION PUMP EXPENDITURES BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS)
  • TABLE 26 U.S. INSULIN INFUSION PUMP EXPENDITURES BY MARKET SECTOR, THROUGH 2014 ($ MILLIONS)

Chapter-7: CONDITIONS

• CONDITIONS PAIN MANAGEMENT
• PAIN MANAGEMENT (CONTINUED)
• MEDICATION
• DIABETES
• ENTERAL NUTRITION
• PN
• ANTIBIOTICS

Chapter-8: COMPETING AND COMPLEMENTARY TECHNOLOGIES

• NEEDLELESS INJECTORS
  • TABLE 27 GLOBAL NEEDLELESS INJECTOR MANUFACTURERS' MARKET SHARE BASED ON DOLLAR SALES, 2008 (%)
  • TABLE 27 (CONTINUED)
• NEEDLELESS INJECTORS (CONTINUED)
• INJECTION PENS
• MINIBAGS
• GLUCOSE MONITORING
• SELF-MONITORING OF BLOOD GLUCOSE
• CGMS
• TRADITIONAL INSULIN DELIVERY
• DISRUPTIVE TECHNOLOGY CHALLENGES
• TRANSDERMAL DRUG DELIVERY
• TRANSDERMAL DRUG DELIVERY (CONTINUED)
• TRANSDERMAL DRUG DELIVERY (CONTINUED)
• TRANSDERMAL DRUG DELIVERY (CONTINUED)
• TRANSDERMAL DRUG DELIVERY (CONTINUED)
• TRANSDERMAL PATCH PUMPS
• INHALED MEDICATIONS AND DEVICES
• Inhaled Medications ... (Continued)
  • TABLE 28 PROGRESS TOWARD NEEDLEFREE VACCINE DELIVERY
  • TABLE 28 (CONTINUED)
  • TABLE 28 (CONTINUED)
  • TABLE 28 (CONTINUED)
  • TABLE 28 (CONTINUED)
  • TABLE 28 (CONTINUED)
• NANOTECHNOLOGY
• NANOTECHNOLOGY (CONTINUED
• BIOTECHNOLOGY
• BIOTECHNOLOGY (CONTINUED)

Chapter-9: GOVERNMENT REGULATIONS

• U.S. FDA
• FDA PRE-MARKET REVIEW
• FDA PRE-MARKET REVIEW PROCESS UNDER SCRUTINY
• FDA REPORTING AND VIGILANCE
• FDA RECALLS
  • TABLE 29 KEY FDA PRODUCT RECALLS: INFUSION PUMPS, 2007 - 2009
  • TABLE 29 (CONTINUED)
  • TABLE 29 (CONTINUED)
  • TABLE 29 (CONTINUED)
  • TABLE 29 (CONTINUED)
  • TABLE 29 (CONTINUED)
• FDA AND STATE AND LOCAL GOVERNMENTS
• MEDICARE AND MEDICAID
• MEDICARE
• MEDICARE NATIONAL GUIDELINES: INFUSION DEVICE COVERAGE
  • TABLE 30 NATIONAL MEDICARE COVERAGE DETERMINATIONS PERTAINING TO INFUSION DEVICES
  • TABLE 30 (CONTINUED)
• MEDICARE AND HOME INFUSION
• Medicare Part A Covers Drugs and Equipment for Hospital and Hospice Stays
• MEDICAID
• Medicaid (Continued)

Chapter-10: CLINICAL GUIDELINES BY PROFESSIONAL GROUPS

• THE JOINT COMMISSION
• ECRI INSTITUTE
• THE INSTITUTE FOR SAFE MEDICATION PRACTICES (ISMP)
• THE ASSOCIATION FOR THE ADVANCEMENT OF MEDICAL INSTRUMENTATION (AAMI)
• THE ISO

Chapter-11: PATIENT SAFETY

• INTRODUCTION
• INFUSION PUMPS
• INSULIN PENS
• NEEDLELESS JET INJECTORS
• IIPS
• ELASTOMERIC INFUSION PUMPS

Chapter-12: INDUSTRY STRUCTURE

• FORCES DRIVING THE INDUSTRY
• CURRENT PERFORMANCE
• INDUSTRY CONTEXT
• MANUFACTURERS
• DISTRIBUTORS
• GOVERNMENTS AND REGULATORY BODIES
• INSURANCE COMPANIES
• HOSPITALS
  • TABLE 31 U.S. HOSPITAL EXPENDITURES ON INFUSION PUMPS BY TECHNOLOGY TYPE, THROUGH 2014 ($ MILLIONS)
• GROUP PURCHASING ORGANIZATIONS
• THE HOME INFUSION SECTOR
  • TABLE 32 U.S. HOME INFUSION PROVIDERS' , INCLUDING PHARMACIES, EXPENDITURES ON INFUSION PUMPS BY TECHNOLOGY TYPE, THROUGH 2014 ($ MILLIONS)
• FULL-SERVICE PROVIDERS
• NURSING CARE PROVIDERS
• DRUG PROVIDERS
• PROVISION OF INFUSION THERAPY SERVICES
• GOVERNMENT
• INFUSION THERAPY DELIVERY MODELS
• INFUSION THERAPY IN AN ALTERNATE SITE
  • TABLE 33 U.S. DOCTORS' OFFICE EXPENDITURES ON INFUSION PUMPS BY TECHNOLOGY TYPE, THROUGH 2014 ($ MILLIONS)
  • TABLE 34 U.S. ALTERNATE SITE EXPENDITURES ON INFUSION PUMPS BY TECHNOLOGY TYPE, THROUGH 2014 ($ MILLIONS)

Chapter-13: INTERNATIONAL ASPECTS

• TABLE 35 GLOBAL INFUSION PUMP EXPENDITURES BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS)
• TABLE 36 GEOGRAPHIC DISTRIBUTION OF MAJOR MANUFACTURERS' SALES (%)
• INTERNATIONAL REGULATIONS
  • TABLE 37 SIGNIFICANT INTERNATIONAL REGULATORY ACTION
• AUSTRALIA
• CANADA
• EUROPEAN UNION
• JAPAN
• REST OF ASIA
• Rest of Asia (Continued)

Chapter-14: TRENDS IN PRICE AND PRICE/PERFORMANCE

• GENERAL INFUSION PUMP
• PV/LCC ANALYSIS ASSUMPTIONS
• INSULIN PUMPS
  • TABLE 38 COMPARING COSTS OF INSULIN ADMINISTRATION METHODS ($)
• OTHER FACTORS INFLUENCING DEMAND
• COST
• CLINICAL EFFECTIVENESS
• ERRORS
• SMART INFRASTRUCTURE
• TRAINING
• Training Time
• DEMOGRAPHICS
• General
  • TABLE 39 DEMOGRAPHIC PROJECTIONS THROUGH 2050 (POPULATION IN MILLIONS)
  • TABLE 40 AGING OF WORLD POPULATION, 2000 AND 2014
• Diabetes
  • TABLE 41 GLOBAL INCIDENCE OF DIABETES, 2000 AND 2030
  • TABLE 42 LEADING COUNTRIES, DIABETES, 2000 AND 2030 (MILLIONS)
• Cancer
• U.S.
• MARKET SATURATION
• Market Saturation /Continued)

Chapter-15: TECHNOLOGY, INCLUDING PATENT EVALUATION

• TECHNOLOGY, INCLUDING PATENT EVALUATION
• TECHNOLOGY, INCLUDING PATENT ... (CONTINUED)
  • TABLE 43 U.S. MEDICATORS AND RECEPTORS PATENTS, GENERAL ACTIVITY IN SELECTED COMPANIES, 2004 - 2008
  • TABLE 43 (CONTINUED)
  • TABLE 44 GLOBAL PATENT ACTIVITY IN INFUSION PUMP TECHNOLOGIES, 2005 - 2009
  • TABLE 44 (CONTINUED)
• PATENT ACTIVITY 2009: ELASTOMERIC INFUSION PUMPS
  • TABLE 45 GLOBAL PATENT ACTIVITY 2009: ELASTOMERIC INFUSION PUMPS
• PATENT ACTIVITY 2009: INJECTION PENS
  • TABLE 46 GLOBAL PATENT ACTIVITY 2009: INJECTION PENS
• PATENT ACTIVITY 2009: NEEDLELESS INJECTOR JETS
  • TABLE 47 GLOBAL PATENT ACTIVITY 2009: NEEDLELESS INJECTOR JETS
• PATENT ACTIVITY 2009: MECHANICAL INFUSION PUMPS
  • TABLE 48 GLOBAL PATENT ACTIVITY 2009: MECHANICAL INFUSION PUMPS
  • TABLE 48 (CONTINUED)
• PATENT ACTIVITY 2009: SYRINGE PUMPS

Chapter-16: COMPANY PROFILES

• INFUSION PUMPS
• ALARIS MEDICAL SYSTEMS, INC.
• BAXA
• B. BRAUN MELSUNGEN AG
• B. Braun Medical, Inc.
• BAXTER INT' L, INC.
• CAREFUSION
• COVIDIEN, PLC/KENDALL
• Kendall
• KENDALL CO.
• FRESENIUS KABI AG
• HOSPIRA, INC.
• KIMBERLY-CLARK CORP./I-FLOW
• I-FLOW CORP.
• LMA INT' L
• LMA North America, Inc.
• MOOG, INC.
• SIGMA INT' L
• SMITHS MEDICAL
• STRYKER CORP.
• TERUMO CORP.
• Terumo Medical Corp.
• ZHUKAI FORNIA
• Ashlar Holdings, LLC
• INSULIN PUMPS
• ANIMAS CORP.
• DEBIOTECH
• INSULET CORP.
• JOHNSON & JOHNSON CO.
• Animas
• Codman & Shurtleff, Inc.
• MEDINGO MEDICAL SOLUTIONS
• Medingo Medical Solutions U.S.
• MEDTRONIC, INC.
• MEDTRONIC DIABETES
• NIPRO CORP.
• Nipro Diabetes Systems
• ROCHE DIAGNOSTICS CORP.
• SOOIL DEVELOPMENT
• SOOIL Development U.S.
• NEEDLELESS INJECTORS
• ANTARES PHARMA, INC.
• BIOJECT MEDICAL TECHNOLOGIES, INC.
• CROSSJECT
• INJEX-EQUIDYNE SYSTEMS
• NATIONAL MEDICAL PRODUCTS, INC.
• PFIZERM, INC.
• ZOGENIX
• MINIBAGS
• INHALED/TRANSDERMAL DRUG DELIVERY SYSTEMS
• 3M DRUG DELIVERY SYSTEMS
• ALKERMES, INC.
• ARADIGM CORP.
• MANNKIND CORP.
• VECTURA
• INJECTION PENS
• NOVO NORDISK A/S
• Novo Nordisk U.S.
• Novo Nordisk U.S. (Continued)
• OWEN MUMFORD, LTD.
• YPSOMED
• Ypsomed (Continued)

Chapter-17: APPENDIX

• APPENDIX
  • TABLE 49 GLOBAL PATENTS AND PATENT APPLICATIONS BY COMPANY, 2009
  • TABLE 49 (CONTINUED)
  • TABLE 49 (CONTINUED)
  • TABLE 49 (CONTINUED)
  • TABLE 49 (CONTINUED)

Press Release

輸液幫浦部門戲劇性的變革正熾中

相關商品

矚目市場調查報告書

全套市場調查報告定期訂閱

Market Research Report Subscription

BCC Research發行的醫療設備相關市場調查報告書

全球家用醫療設備市場及技術:新興市場的焦點

Global Markets and Technologies for Home Medical Equipment--Focus on Emerging Markets

價格 : US $ 3900

出版日期 : 2012年03月

對全球家用醫療設備市場及技術:金磚四國的焦點

Global Markets and Technologies for Home Medical Equipment--Focus on BRIC Countries

價格 : US $ 3900

出版日期 : 2012年03月

全球家用醫療設備市場及技術:日本市場的焦點

Global Markets and Technologies for Home Medical Equipment--Focus on Japan

價格 : US $ 3900

出版日期 : 2012年03月

Email Alert(Email 通知) - 最新市場調查報告書

GII 將每天定期更新最新市場調查報書資訊，選擇您有興趣的市場分類，我們將用Email的方式讓您收到最新訊息!